b'THE ALTASCIENTISTThedevelopmentofantisenseoligonucleotides(ASOs)isshowing promiseintherapeuticapplicationsforanumberofdiseases,both neurological and non-neurological. The accurate quantification of ASOs in complex biological tissues requires robust and sensitive bioanalytical assays that minimize interference, an area in which Altasciences has significant expertise.In this issue of The Altascientist, we provide an overview of the evolvingASOtherapeutic approach,andpresenttwo casestudiesdemonstrating our capabilities in the field.DOWNLOAD YOUR COPYView all issues of The Altascientist.'